417 related articles for article (PubMed ID: 11500228)
1. Veterinary drug delivery: potential for skin penetration enhancement.
Magnusson BM; Walters KA; Roberts MS
Adv Drug Deliv Rev; 2001 Sep; 50(3):205-27. PubMed ID: 11500228
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
Kanikkannan N; Kandimalla K; Lamba SS; Singh M
Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
[TBL] [Abstract][Full Text] [Related]
3. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
Ita KB
Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
[TBL] [Abstract][Full Text] [Related]
4. Potential and problems of developing transdermal patches for veterinary applications.
Riviere JE; Papich MG
Adv Drug Deliv Rev; 2001 Sep; 50(3):175-203. PubMed ID: 11500227
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transdermal drug delivery techniques: an extensive review of patents.
Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571
[TBL] [Abstract][Full Text] [Related]
6. Chemical penetration enhancers in stratum corneum - Relation between molecular effects and barrier function.
Pham QD; Björklund S; Engblom J; Topgaard D; Sparr E
J Control Release; 2016 Jun; 232():175-87. PubMed ID: 27108613
[TBL] [Abstract][Full Text] [Related]
7. Novel penetration enhancers for skin applications: a review.
Parhi R; Suresh P; Mondal S; Kumar PM
Curr Drug Deliv; 2012 Mar; 9(2):219-30. PubMed ID: 22023208
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
9. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
Herman A; Herman AP
J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
[TBL] [Abstract][Full Text] [Related]
10. Penetration enhancers.
Williams AC; Barry BW
Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the skin permeation barrier: challenges and opportunities.
Vitorino C; Sousa J; Pais A
Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
[TBL] [Abstract][Full Text] [Related]
12. Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the
Schafer N; Balwierz R; Biernat P; Ochędzan-Siodłak W; Lipok J
Mol Pharm; 2023 Jul; 20(7):3278-3297. PubMed ID: 37279070
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
Amjadi M; Mostaghaci B; Sitti M
Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
[TBL] [Abstract][Full Text] [Related]
14. Permeation enhancers in transdermal drug delivery: benefits and limitations.
Kováčik A; Kopečná M; Vávrová K
Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
[No Abstract] [Full Text] [Related]
15. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.
Chen Y; Wang M; Fang L
Drug Deliv; 2013; 20(5):199-209. PubMed ID: 23763451
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery systems. 6. Transdermal drug delivery.
Ranade VV
J Clin Pharmacol; 1991 May; 31(5):401-18. PubMed ID: 2050824
[TBL] [Abstract][Full Text] [Related]
17. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
Patil UK; Saraogi R
Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the stratum corneum: the modulation of skin penetration. A review.
Trommer H; Neubert RH
Skin Pharmacol Physiol; 2006; 19(2):106-21. PubMed ID: 16685150
[TBL] [Abstract][Full Text] [Related]
19. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic transdermal permeation enhancers: structure-activity relationships.
Vávrová K; Zbytovská J; Hrabálek A
Curr Med Chem; 2005; 12(19):2273-91. PubMed ID: 16178785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
